Outcome of the Board Meeting held on Tuesday, 22nd July, 2025 pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 1.7 pts less than Nifty Microcap 250 and 1.9 pts less than its Stockbroking & Allied peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Swastika Investmart's board, at its July 22, 2025 meeting, approved un-audited standalone and consolidated financial results for Q1 FY26 (quarter ended June 30, 2025). On a standalone basis, total revenue from operations fell to Rs. 2,575.65 lakhs from Rs. 3,702.11 lakhs a year ago, a decline of roughly 30% year-on-year, while net profit dropped to Rs. 341.69 lakhs from Rs. 616.45 lakhs, down about 44.6%. Basic EPS stood at Rs. 1.89 versus Rs. 4.17 in the year-ago quarter. However, profit after tax improved sequentially from Rs. 270.27 lakhs in Q4 FY25. The board also approved the redesignation of Mr. Devashish Nyati from Chief Technology Officer to Chief Technology and Security Officer, with added responsibility as the designated officer for the Cyber Security and Cyber Resilience Framework. Additionally, the company disclosed it sold a 70% stake in its wholly-owned subsidiary Swastika Insurance Broking Services Limited on June 12, 2025 for Rs. 84 lakhs, booking a Rs. 31.50 lakhs gain on disposal. Remaining 5,57,000 warrants were converted into 27,85,000 equity shares, and a new Employee Stock Option Scheme 2025 covering up to 3,10,000 stock options was approved.
Sharp year-on-year declines in both revenue and profit point to weak Q1 performance, though the sequential recovery in PAT and absence of any qualified auditor opinion limit near-term alarm. Shareholders should note the equity dilution from warrant conversion and the ESOP 2025 scheme, as well as the loss of control over the insurance broking subsidiary, which has now been reclassified as an associate.